Dow Dips Over 300 Points; US Initial Claims Rise - Aveanna Healthcare Hldgs ( NASDAQ:AVAH ) , Brilliant Earth Group ( NASDAQ:BRLT )
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 300 points on Thursday. The Dow traded down 0.74% to 43,864.15 while the NASDAQ fell 0.27% to 21,113.04. The S&P 500 also fell, dropping, 0.45% to 6,316.34. Utilities shares jumped by 1.2% on Thursday.
Nasdaq Surges Over 150 Points; ConocoPhillips Earnings Top Estimates - Bit Origin ( NASDAQ:BTOG ) , Brilliant Earth Group ( NASDAQ:BRLT )
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 150 points on Thursday. Following the market opening Thursday, the Dow traded down 0.04% to 44,174.56 while the NASDAQ gained 0.83% to 21,345.90. The S&P 500 also rose, gaining, 0.32% to 6,365.19.
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - ADMA Biologics ( NASDAQ:ADMA ) , Airbnb ( NASDAQ:ABNB )
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Thursday. Shares of Redwire Corporation RDW fell sharply in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY25 sales guidance.
Sana Biotechnology Announces Pricing of Public Offering - Sana Biotechnology ( NASDAQ:SANA )
SEATTLE, Aug. 06, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc.
Sana Biotechnology Announces Pricing of Public Offering
SEATTLE, Aug. 06, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc. ( Nasdaq: SANA ) ( "Sana" ) , a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public offering of 20,895,522 shares of its common stock at a ...
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
SEATTLE, Aug. 06, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc. ( Nasdaq: SANA ) ( "Sana" ) , a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 million of shares of its common ...
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes - Eli Lilly ( NYSE:LLY ) , DexCom ( NASDAQ:DXCM )
In a public post in May, I wrote about Sana Biotechnology, Inc. SANA, a biotech that has developed a potential cure for type 1 diabetes. Here's an update on developments since. Functional-cure potential. Sana's hypo-immune ( HIP ) edits let donor islet cells make insulin without triggering ...
Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday - Circle Internet Group ( NYSE:CRCL ) , AIRO Group Holdings ( NASDAQ:AIRO )
U.S. stocks were higher, with the Dow Jones index gaining around 50 points on Monday. Shares of Tesla, Inc. TSLA rose sharply during Monday's session amid the Robotaxi launch in Austin, TX.
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without Immunosuppression ...
Two Biotech Stocks Poised For Big Moves On Monday - Lineage Cell Therapeutics ( AMEX:LCTX ) , Roche Holding ( OTC:RHHBY )
Two Biotechs Poised For Big Moves On Monday ( Sana Biotechnology | Lineage Cell Therapeutics ) Catalyst: Invited six-month clinical update - ADA Scientific Sessions, Monday @ 10:30 a.m. CT ir.sana.comglobenewswire.com Audience effect: the ADA meeting pulls in ~11-12 k registrants.
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients with type 1 diabetes Presentation to highlight updated six-month clinical results of a hypoimmune-modified primary pancreatic islet cell therapy for patients ...
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions - Sana Biotechnology ( NASDAQ:SANA )
SEATTLE, June 09, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc.
Sana Biotechnology to Present at June 2025 Investor Conferences - Sana Biotechnology ( NASDAQ:SANA )
SEATTLE, May 28, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc. SANA, a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. The presentations will feature a business ...
Sana Biotechnology to Present at June 2025 Investor Conferences
SEATTLE, May 28, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc. ( NASDAQ: SANA ) , a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June.
The End Of The Diabetes Industry? - Eli Lilly ( NYSE:LLY ) , DexCom ( NASDAQ:DXCM )
Years ago, in a conversation with an endocrinologist, I mentioned there was no incentive to cure diabetes, giving the money companies were making from managing it ( with testing supplies, insulin, etc. ) . He replied that the incumbents had no incentive to cure it, but a startup company would.
Investors in Sana Biotechnology, Inc. ( SANA ) : Protect Your Rights - Contact Levi & Korsinsky Before May 20, 2025
Investors in Sana Biotechnology, Inc. (SANA): Protect Your Rights - Contact Levi & Korsinsky Before May ...
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Sana To Contact Him Directly To Discuss Their Options
SANA DEADLINE NOTICE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sana Biotechnology, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 20 Deadline in Securities...
New York, New York-- ( Newsfile Corp. - May 18, 2025 ) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. ( NASDAQ: SANA ) between March 17, 2023 and November 4, 2024, inclusive ( the "Class Period" ) , of the important May 20, ...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Sana To Contact Him Directly To Discuss Their Options
Sana Biotechnology, Inc. Class Action: Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, May 16, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ( "Sana Biotechnology, Inc." or the "Company" ) SANA of a class action securities lawsuit.
May 20, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, May 15, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. SANA. Shareholders who purchased shares of SANA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sana To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sana To Contact Him Directly To Discuss Their Options
Sana Biotechnology, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA
NEW YORK, NY / ACCESS Newswire / May 11, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. ( NASDAQ:SANA ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E.
Sana Biotechnology, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, May 07, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. SANA. Shareholders who purchased shares of SANA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, May 04, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. ( "Sana" or "the Company" ) SANA and certain of its officers.
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 30, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. SANA between March 17, 2023 and November 4, 2024, inclusive ( the "Class Period" ) , of the important May 20, 2025 lead plaintiff ...
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 27, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. ( "Sana" or "the Company" ) SANA and certain of its officers.
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Sana To Contact Him Directly To Discuss Their Options
Levi & Korsinsky Reminds Sana Biotechnology, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 24, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ( "Sana Biotechnology, Inc." or the "Company" ) SANA of a class action securities lawsuit.
ROSEN, A RANKED AND LEADING FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. SANA between March 17, 2023 and November 4, 2024, inclusive ( the "Class Period" ) , of the important May 20, 2025 lead plaintiff ...
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sana To Contact Him Directly To Discuss Their Options
Lost Money on Sana Biotechnology, Inc. ( SANA ) ? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 18, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ( "Sana Biotechnology, Inc." or the "Company" ) SANA of a class action securities lawsuit.
Shareholders of Sana Biotechnology, Inc. Should Contact Levi & Korsinsky Before May 20, 2025 to Discuss Your Rights - SANA
NEW YORK, NY / ACCESS Newswire / April 18, 2025 / If you suffered a loss on your Sana Biotechnology, Inc. ( NASDAQ:SANA ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E.
Contact The Gross Law Firm by May 20, 2025 Deadline to Join Class Action Against Sana Biotechnology, Inc. ( SANA ) - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 17, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Sana Biotechnology, Inc. SANA. Shareholders who purchased shares of SANA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
Sana Biotechnology, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. May 20, 2025 Deadline to file Lead Plaintiff Motion. - Sana Biotechnology ( NASDAQ:SANA )
Investors can contact the law firm at no cost to learn more about recovering their losses
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 15, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. SANA between March 17, 2023 and November 4, 2024, inclusive ( the "Class Period" ) , of the important May 20, 2025 lead plaintiff ...
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 13, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. ( "Sana" or "the Company" ) SANA and certain of its officers.
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sana To Contact Him Directly To Discuss Their Options
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 12, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. SANA between March 17, 2023 and November 4, 2024, inclusive ( the "Class Period" ) , of the important May 20, 2025 lead plaintiff ...
ROSEN, A LEADING AND RANKED FIRM, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. SANA between March 17, 2023 and November 4, 2024, inclusive ( the "Class Period" ) , of the important May 20, 2025 lead plaintiff ...
SANA Stockholders Should Contact Shareholder Rights Law Firm Robbins LLP for Information on How to Lead the Class Action Against Sana Biotechnology, Inc. - Sana Biotechnology ( NASDAQ:SANA )
SAN DIEGO, April 07, 2025 ( GLOBE NEWSWIRE ) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Sana Biotechnology, Inc. SANA securities between March 17, 2023 and November 4, 2024.
Faruqi & Faruqi Reminds Sana Biotechnology Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2025 - SANA - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Sana To Contact Him Directly To Discuss Their Options
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sana Biotechnology, Inc. ( SANA ) Shareholders
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sana Biotechnology, Inc.(SANA) Shareholders ...
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 05, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sana Biotechnology, Inc. SANA between March 17, 2023 and November 4, 2024, inclusive ( the "Class Period" ) , of the important May 20, 2025 lead plaintiff ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 02, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Sana Biotechnology, Inc. SANA between March 17, 2023 and November 17, 2024, inclusive ( the "Class ...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology - Sana Biotechnology ( NASDAQ:SANA )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Sana To Contact Him Directly To Discuss Their Options
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday - Arcellx ( NASDAQ:ACLX ) , Allegiant Travel ( NASDAQ:ALGT )
U.S. stocks were lower, with the Dow Jones index falling over 100 points on Wednesday. Shares of Cognyte Software Ltd. CGNT rose sharply during Wednesday's session after the company reported better-than-expected fourth-quarter financial results.
Levi & Korsinsky Notifies Sana Biotechnology, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SANA - Sana Biotechnology ( NASDAQ:SANA )
NEW YORK, April 01, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Sana Biotechnology, Inc. ( "Sana Biotechnology, Inc." or the "Company" ) SANA of a class action securities lawsuit.
Flagship Pioneering Announces Agreement Between Pioneering Medicines and Pfizer to Discover Potential Novel, Selective Inhibitors for Autoimmune Disease - Foghorn Therapeutics ( NASDAQ:FHTX ) , Moderna ( NASDAQ:MRNA )
Collaboration leverages Logica, a platform offering from Valo Health and Charles River that directly translates biological insights into optimized small molecules
